Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): 3-year follow-up of a randomised, controlled trial.

Hancock M, Smith A, O'Sullivan P, Schütze R, Caneiro JP, Laird R, O'Sullivan K, Hartvigsen J, Campbell A, Wareham D, Chang R, Kent P

Open source

DOI
10.1016/s2665-9913(25)00135-3
Published
2025 Nov
Container
The Lancet. Rheumatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2665-9913-25-00135-3,
  title = {Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): 3-year follow-up of a randomised, controlled trial.},
  author = {Hancock M and Smith A and O'Sullivan P and Schütze R and Caneiro JP and Laird R and O'Sullivan K and Hartvigsen J and Campbell A and Wareham D and Chang R and Kent P},
  year = {2025},
  journal = {The Lancet. Rheumatology},
  doi = {10.1016/s2665-9913(25)00135-3},
  url = {https://doi.org/10.1016/s2665-9913(25)00135-3}
}

RIS

TY  - JOUR
TI  - Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): 3-year follow-up of a randomised, controlled trial.
AU  - Hancock M
AU  - Smith A
AU  - O'Sullivan P
AU  - Schütze R
AU  - Caneiro JP
AU  - Laird R
AU  - O'Sullivan K
AU  - Hartvigsen J
AU  - Campbell A
AU  - Wareham D
AU  - Chang R
AU  - Kent P
PY  - 2025
JO  - The Lancet. Rheumatology
DO  - 10.1016/s2665-9913(25)00135-3
UR  - https://doi.org/10.1016/s2665-9913(25)00135-3
ER  - 

APA

M, H., A, S., P, O., R, S., JP, C., R, L., K, O., J, H., A, C., D, W., R, C., & P, K. (2025). Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): 3-year follow-up of a randomised, controlled trial.. The Lancet. Rheumatology. https://doi.org/10.1016/s2665-9913(25)00135-3

Source records